This Slide: #75 of 100 |
Slide #75. Radiometer Medical ApS — Quest Diagnostics HemoCue Business
Acquirer:
Radiometer Medical ApS
Acquiree:
Quest Diagnostics HemoCue Business (NYSE:DGX)
Details:
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has completed the sale of its HemoCue diagnostic products business to Radiometer Medical ApS for a purchase price of approximately $300 million plus customary adjustments for cash balances. HemoCue develops, produces and markets hemoglobin, glucose and other point-of-care testing systems worldwide.
Open the DGX Page at The Online Investor »
|
Open the DGX Page at The Online Investor (in a new window) »
Free DGX Email Alerts: Get SEC Filing Alerts Get Dividend Alerts |
Buy (2.53 out of 4) 100th percentile
(ranked higher than approx. 100% of all stocks covered)
Analysts' Target Price: DGX Stock Forecast Based on Zacks ABR data; powered by Xignite |